Decoding the Role of Caveolin-1 in Morphological Diversity and Self-Renewal of Breast Cancer Cells

Abstract

Cellular geometry is tightly associated with the function of a cell. During tumour progression, cancer cells undergo changes in phenotypes and biological behaviour with deformations in cellular morphology. However, whether the morphological diversity of cancer cells correlates with the cellular phenotype, and the underlying mechanism of morphology-related function in cancer cells is still unclear. Here, we simplified the cellular morphology by clustering cancer cells into three categories based on two-dimensional cellular morphological features. The silence of caveolin-1 (Cav-1), the primary constituent of membrane caveolae, reproduced the morphological evolutionary behaviour of cancer cells, which is similar to the epithelial-mesenchymal transition process. The attenuation of dorsal stress fibres, the assembly of focal adhesions and the disorder of transverse arc fibres and their regulatory signals are demonstrated as the main morphological evolutionary tools of cancer cells. Moreover, a modified vertex model theoretically reconfirmed the evolutionary process of cellular morphology. Small GTPases and focal adhesion kinase signalling were implicated in Cav-1 knockdown-induced cytoskeletal remodelling and focal adhesion assembly. Both in vitro and in vivo studies have demonstrated that Cav-1-dependent morphological changes are closely associated with the self-renewal capacity of breast cancer cells. Overall, our work highlights new insight into the morphological diversity and the correlation between cellular shape and phenotype of cancer cells, and provides evidence that Cav-1 could affect cancer cell properties such as self-renewal capacity through maintaining the morphological stability.

Keywords

cancer cell morphology / caveolin-1 / cytoskeleton rebuilding / focal adhesions / self-renewal ability

References

[1] K. T. Navya, K. Prasad, and B. M. K. Singh, “Analysis of Red Blood Cells From Peripheral Blood Smear Images for Anemia Detection: A Methodological Review,” Medical & Biological Engineering & Computing 60, no. 9 (2022): 2445–2462.

[2] A. Prasad and E. Alizadeh, “Cell Form and Function: Interpreting and Controlling the Shape of Adherent Cells,” Trends in Biotechnology 37, no. 4 (2019): 347–357.

[3] J. P. Thiery, H. Acloque, R. Y. J. Huang, and M. A. Nieto, “Epithelial-Mesenchymal Transitions in Development and Disease,” Cell 139, no. 5 (2009): 871–890.

[4] D. G. Kong, C. J. Hughes, and H. L. Ford, “Cellular Plasticity in Breast Cancer Progression and Therapy,” Frontiers in Molecular Biosciences 7 (2020): 72.

[5] S. Y. Qin, J. W. Jiang, Y. Lu, et al., “Emerging Role of Tumor Cell Plasticity in Modifying Therapeutic Response,” Signal Transduction and Targeted Therapy 5, no. 1 (2020): 228.

[6] R. Kalluri and R. A. Weinberg, “The Basics of Epithelial-Mesenchymal Transition,” Journal of Clinical Investigation 119, no. 6 (2009): 1420–1428.

[7] L. A. Hapach, J. A. Mosier, W. J. Wang, and C. A. Reinhart-King, “Engineered Models to Parse Apart the Metastatic Cascade,” npj Precision Oncology 3 (2019): 20.

[8] Z. Yin, A. Sadok, H. Sailem, et al., “A Screen for Morphological Complexity Identifies Regulators of Switch-Like Transitions Between Discrete Cell Shapes,” Nature Cell Biology 15, no. 7 (2013): 860–871.

[9] S. K. Y. Ma, A. S. F. Chan, A. Rubab, W. C. W. Chan, and D. Chan, “Extracellular Matrix and Cellular Plasticity in Musculoskeletal Development,” Frontiers in Cell and Development Biology 8 (2020): 781.

[10] A. Saraswathibhatla, D. Indana, and O. Chaudhuri, “Cell-Extracellular Matrix Mechanotransduction in 3D,” Nature Reviews Molecular Cell Biology 24, no. 7 (2023): 495–516.

[11] A. Datta, S. Deng, V. Gopal, et al., “Cytoskeletal Dynamics in Epithelial-Mesenchymal Transition: Insights Into Therapeutic Targets for Cancer Metastasis,” Cancers 13, no. 8 (2021): 1882.

[12] S. M. Lyons, E. Alizadeh, J. Mannheimer, et al., “Changes in Cell Shape Are Correlated With Metastatic Potential in Murine and Human Osteosarcomas,” Biology Open 5, no. 3 (2016): 289–299.

[13] A. Sistigu, F. Di Modugno, G. Manic, and P. Nisticò, “Deciphering the Loop of Epithelial-Mesenchymal Transition, Inflammatory Cytokines and Cancer Immunoediting,” Cytokine & Growth Factor Reviews 36 (2017): 67–77.

[14] A. Dongre and R. A. Weinberg, “New Insights Into the Mechanisms of Epithelial-Mesenchymal Transition and Implications for Cancer,” Nature Reviews Molecular Cell Biology 20, no. 2 (2019): 69–84.

[15] S. Chettimada, J. Yang, H. G. Moon, and Y. Jin, “Caveolae, Caveolin-1 and Cavin-1: Emerging Roles in Pulmonary Hypertension,” World Journal of Respirology 5, no. 2 (2015): 126–134.

[16] A. F. Quest, J. L. Gutierrez-Pajares, and V. A. Torres, “Caveolin-1: An Ambiguous Partner in Cell Signalling and Cancer,” Journal of Cellular and Molecular Medicine 12, no. 4 (2008): 1130–1150.

[17] D. Zhang, A. L. Gava, R. Van Krieken, et al., “The Caveolin-1 Regulated Protein Follistatin Protects Against Diabetic Kidney Disease,” Kidney International 96, no. 5 (2019): 1134–1149.

[18] S. Shetty and S. Idell, “Caveolin-1-Related Intervention for Fibrotic Lung Diseases,” Cells 12, no. 4 (2023): 554.

[19] D. J. Tang, Y. Zhang, J. Mei, J. Zhao, C. L. Miao, and Y. Jiu, “Interactive Mechanisms Between Caveolin-1 and Actin Filaments or Vimentin Intermediate Filaments Instruct Cell Mechanosensing and Migration,” Journal of Molecular Cell Biology 14, no. 11 (2023): mjac066.

[20] A. Grande-García, A. Echarri, J. de Rooij, et al., “Caveolin-1 Regulates Cell Polarization and Directional Migration Through Src Kinase and Rho GTPases,” Journal of Cell Biology 177, no. 4 (2007): 683–694.

[21] J. G. Goetz, S. Minguet, I. Navarro-Lérida, et al., “Biomechanical Remodeling of the Microenvironment by Stromal Caveolin-1 Favors Tumor Invasion and Metastasis,” Cell 146, no. 1 (2011): 148–163.

[22] A. F. G. Quest, L. Lobos-González, S. Nuñez, et al., “The Caveolin-1 Connection to Cell Death and Survival,” Current Molecular Medicine 13, no. 2 (2013): 266–281.

[23] S. Q. Wang, N. Wang, Y. F. Zheng, et al., “Caveolin-1 Inhibits Breast Cancer Stem Cells via c-Myc-Mediated Metabolic Reprogramming,” Cell Death & Disease 11, no. 6 (2020): 450.

[24] B. Joshi, S. S. Strugnell, J. G. Goetz, et al., “Phosphorylated Caveolin-1 Regulates rho/ROCK-Dependent Focal Adhesion Dynamics and Tumor Cell Migration and Invasion,” Cancer Research 68, no. 20 (2008): 8210–8220.

[25] S. Li, Y. Chen, Y. H. Zhang, et al., “Shear Stress Promotes Anoikis Resistance of Cancer Cells via Caveolin-1-Dependent Extrinsic and Intrinsic Apoptotic Pathways,” Journal of Cellular Physiology 234, no. 4 (2019): 3730–3743.

[26] C. Stringer, T. Wang, M. Michaelos, and M. Pachitariu, “Cellpose: A Generalist Algorithm for Cellular Segmentation,” Nature Methods 18, no. 1 (2021): 100–106.

[27] J. MacQueen, “Some Methods for Classification and Analysis of Multivariate Observations,” Proceedings of the Fifth Berkeley Symposium on Mathematical Statistics and Probability 1 (1967): 281–297.

[28] L.v.d. M.a. G. Hinton, “Visualizing Data Using t-SNE,” Journal of Machine Learning Research 9, no. 86 (2008): 2579–2605.

[29] S. Li, Z. Y. Liu, H. Li, et al., “Basal Actomyosin Pulses Expand Epithelium Coordinating Cell Flattening and Tissue Elongation,” Nature Communications 15, no. 1 (2024): 3000.

[30] A. Saraswathibhatla and J. Notbohm, “Tractions and Stress Fibers Control Cell Shape and Rearrangements in Collective Cell Migration,” Physical Review X 10, no. 1 (2020): 011016.

[31] R. G. Hodge and A. J. Ridley, “Regulating Rho GTPases and Their Regulators,” Nature Reviews Molecular Cell Biology 17, no. 8 (2016): 496–510.

[32] E. Crosas-Molist, R. Samain, L. Kohlhammer, et al., “Rho GTPase Signaling in Cancer Progression and Dissemination,” Physiological Reviews 102, no. 1 (2022): 455–510.

[33] A. Hall, “Rho GTPases and the Actin Cytoskeleton,” Science 279, no. 5350 (1998): 509–514.

[34] S. K. Mitra, D. A. Hanson, and D. D. Schlaepfer, “Focal Adhesion Kinase: In Command and Control of Cell Motility,” Nature Reviews Molecular Cell Biology 6, no. 1 (2005): 56–68.

[35] K. Keren, Z. Pincus, G. M. Allen, et al., “Mechanism of Shape Determination in Motile Cells,” Nature 453, no. 7194 (2008): 475–480.

[36] M. Murrell, P. W. Oakes, M. Lenz, and M. L. Gardel, “Forcing Cells Into Shape: The Mechanics of Actomyosin Contractility,” Nature Reviews Molecular Cell Biology 16, no. 8 (2015): 486–498.

[37] K. A. Cho, S. J. Ryu, Y. S. Oh, et al., “Morphological Adjustment of Senescent Cells by Modulating Caveolin-1 Status,” Journal of Biological Chemistry 279, no. 40 (2004): 42270–42278.

[38] X. M. Shi, Z. Y. Wen, Y. J. Wang, Y. J. Liu, K. Shi, and Y. M. Jiu, “Feedback-Driven Mechanisms Between Phosphorylated Caveolin-1 and Contractile Actin Assemblies Instruct Persistent Cell Migration,” Frontiers in Cell and Developmental Biology 9 (2021): 665919.

[39] B. Sinha, D. Köster, R. Ruez, et al., “Cells Respond to Mechanical Stress by Rapid Disassembly of Caveolae,” Cell 144, no. 3 (2011): 402–413.

[40] C. A. O'Brien, A. Kreso, and C. H. M. Jamieson, “Cancer Stem Cells and Self-Renewal,” Clinical Cancer Research 16, no. 12 (2010): 3113–3120.

[41] J. W. Hu, S. Mirshahidi, A. Simental, et al., “Cancer Stem Cell Self-Renewal as a Therapeutic Target in Human Oral Cancer,” Oncogene 38, no. 27 (2019): 5440–5456.

[42] L. Yang, P. Shi, G. Zhao, et al., “Targeting Cancer Stem Cell Pathways for Cancer Therapy,” Signal Transduction and Targeted Therapy 5, no. 1 (2020): 8.

[43] P. Rangamani, A. Lipshtat, E. U. Azeloglu, et al., “Decoding Information in Cell Shape,” Cell 154, no. 6 (2013): 1356–1369.

[44] S. Li, K. Yang, X. Chen, et al., “Simultaneous 2D and 3D Cell Culture Array for Multicellular Geometry, Drug Discovery and Tumor Microenvironment Reconstruction,” Biofabrication 13, no. 4 (2021): 045013.

[45] C. Uhler and G. V. Shivashankar, “Regulation of Genome Organization and Gene Expression by Nuclear Mechanotransduction,” Nature Reviews Molecular Cell Biology 18, no. 12 (2017): 717–727.

[46] Y. Song, J. Soto, B. Chen, et al., “Transient Nuclear Deformation Primes Epigenetic State and Promotes Cell Reprogramming,” Nature Materials 21, no. 10 (2022): 1191–1199.

[47] P. Friedl and K. Wolf, “Tumour-Cell Invasion and Migration: Diversity and Escape Mechanisms,” Nature Reviews. Cancer 3, no. 5 (2003): 362–374.

[48] R. J. Petrie, H. Koo, and K. M. Yamada, “Generation of Compartmentalized Pressure by a Nuclear Piston Governs Cell Motility in a 3D Matrix,” Science 345, no. 6200 (2014): 1062–1065.

RIGHTS & PERMISSIONS

2025 The Author(s). Cell Proliferation published by Beijing Institute for Stem Cell and Regenerative Medicine and John Wiley & Sons Ltd.